NativeMed review

NativeMed for mothers: our verdict

Compounded semaglutide at $149 and tirzepatide at $183, both advertised as sale prices against $299 and $399, with no membership fee and pharmacies described only as USA-based. ⚠ NativeMed carries an FDA warning letter of its own — issued to NativeMed LLC dba NativeMed on 8 June 2026, MARCS-CMS 728287, for false and misleading claims and misbranding in telehealth. We list it and disclose the letter rather than dropping it, because a letter tells you something a reader should weigh and only a shutdown ends a listing. The storefront also sells NAD+ injections and generic sildenafil, tadalafil and trazodone alongside the GLP-1s, so it is a general telehealth catalog rather than a weight-loss practice. It runs about $149/month, flat across every dose — toward the affordable end of what we track.

We weigh NativeMed the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a general weight-loss roundup leaves out.

What NativeMed costs, in full

• Compounded semaglutide — Injectable, sale price: $149/mo
• Compounded tirzepatide — Injectable, sale price: $183/mo

That sits below the roughly $179 median ongoing price across the providers we track for mothers — a real cost advantage.

NativeMed says the price covers the provider visit and the medication. That is the comparison that matters at this price: two providers a few dollars apart can differ by a hundred a month once the extras are counted, so line up what each one bundles before you decide.

The medications NativeMed prescribes

NativeMed prescribes semaglutide and tirzepatide — the two with the largest published weight-loss effects, and carrying both on one account matters when insulin resistance, common with PCOS and after gestational diabetes, makes tirzepatide the better-suited option. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.

Where NativeMed fits — and where it doesn't — for mothers

A good fit if…

• the monthly cost is a real barrier and you want a low, predictable number.
• switching between semaglutide and tirzepatide may become necessary as your body and your hormones change.

Look elsewhere if…

• you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
• a clean regulatory record is a dealbreaker — note the FDA warning flagged in the cons above.
• you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that is the ground our #1 pick, CoreAge Rx, is built on.

Oversight, safety, and what we could verify

Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. It carries an FDA warning letter, flagged in the cons — read it before starting. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.

One line that applies to every provider on this site: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.

The bottom line

NativeMed is a provider we list only with full disclosure — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.